SKCC Welcomes Dr. Kristin Brill as Enterprise Director of Breast Oncology

Article

In Partnership With:

Breast surgeon Kristin L. Brill MD, has joined the Sidney Kimmel Cancer Center – Jefferson Health as Enterprise Director of Breast Oncology.

Breast surgeon Kristin L. Brill MD, has joined the Sidney Kimmel Cancer Center — Jefferson Health (SKCC) as Enterprise Director of Breast Oncology.

Brill brings expertise in a comprehensive range of services for patients with malignant and benign disease, including breast-conserving surgery, nipple-sparing mastectomy, preventive mastectomy, reconstruction, accelerated partial breast radiation device placement, and clinical trials for breast cancer.

Particular areas of focus for Brill include young women with breast cancer and those at high risk.

"I am thrilled to join the SKCC — Jefferson Health team as the Breast Program enterprise leader," Brill said. "SKCC has a long tradition of excellence in cancer care, research, and innovation, providing unparalleled cancer treatment in our region and beyond. Our goal is to provide the same high-quality services across multiple Jefferson locations, with the mission of improving lives and cancer outcomes."

Brill joins SKCC from Cooper University Health Care, where she was head of the Division of Breast Surgery and Director of the Janet Knowles Breast Cancer Center at MD Anderson Cancer Center at Cooper and Assistant Professor of Surgery at Cooper Medical School of Rowan University in Camden, N.J. She also directed the Breast Surgical Oncology Fellowship at Cooper Medical School and was an adjunct assistant professor in the Department of Surgery at The University of Texas MD Anderson Cancer Center.

"We are enthusiastic to have Dr. Brill join the leadership team of the Sidney Kimmel Cancer Center at Jefferson Health. She is an exceptional breast oncologist who is dedicated to increasing access to the most advanced surgical breast care and will lead Jefferson in developing the next set of technological breakthroughs for breast cancer patients," said Karen E. Knudsen, MBA, PhD, Executive Vice President of Oncology Services and Enterprise Director of SKCC.

"Dr. Brill's recruitment is a key component of the SKCC mission to improve the lives of cancer patients and their families though innovation, compassion, and discovery."

Brill is a Fellow of the American College of Surgeons and is routinely named a "Top Doc" by Philadelphia Magazine and New Jersey Monthly.

She is a member of the American Society of Clinical Oncology, American Society of Breast Surgeons, Society of Surgical Oncology, and the Breastcancer.org advisory board.

After receiving her bachelor’s degree from Gettysburg College in Gettysburg, Pa., Brill received her medical degree from Hahnemann University School of Medicine in Philadelphia. She completed her surgical residency at New York Methodist Hospital in Brooklyn and a breast surgical oncology fellowship at Columbia Presbyterian Medical Center in New York.

Related Videos
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
Carlos Arteaga, MD
Video 2 - "NCCN Guidelines vs Real-World Practice: Risk Stratifying HR+/HER2- Early Breast Cancer"
Reshma L. Mahtani, DO